Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk

Autor: C. Elise Kleyn, Peter S. Talbot, Nehal N. Mehta, Francesca Sampogna, Chris Bundy, Darren M. Ashcroft, Alexa B. Kimball, Peter C.M. van de Kerkhof, Christopher E.M. Griffiths, Fernando Valenzuela, Joelle M. van der Walt, Tsion Aberra, Lluís Puig

Publikováno v: Acta Dermato-Venereologica, Vol 100, Iss 1, p adv00020 (2020)

Psoriasis is a systemic, relapsing, inflammatory disease associated with serious comorbidities including mood problems and/or unhealthy lifestyle behaviours. Cutaneous and systemic abnormalities in innate and acquired immunity play a role in its path

Externí odkaz: https://doaj.org/article/7ffb07d064d74ebdb877c4cfc0d44799

Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council

Autor: Christopher E.M. Griffiths, Tadashi Terui, Peter C.M. van de Kerkhof, Yukari Okubo, Peter Foley, Nicole L. Ward, Mahira Hamdy El-Sayed, Jonathan Barker, Colby C. Evans, Lone Skov, Errol P. Prens, Lluís Puig, Marieke M B Seyger, Andre V. E. de Carvalho, Cristina Eschevarria, Paolo Gisondi, Jashin J. Wu, Marc Bourcier, Caitriona Ryan, Min Zheng, Fernando Valenzuela, Craig L. Leonardi, Andrew Yule Finlay, Masamoto Murakami, Ruth Murphy, Alexa B. Kimball, Bruce Strober, Andrew Blauvelt, Chuck Lynde, Arnon D. Cohen, Joelle M. van der Walt, Robert E. Kalb

Publikováno v: Journal of the American Academy of Dermatology, 82, 1, pp. 117-122
Journal of the American Academy of Dermatology, 82, 117-122

Background Psoriasis severity categories have been important tools for clinicians to use in treatment decisions as well as to determine eligibility criteria for clinical studies. However, owing to the heterogeneity of severity classifications and the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952f79839f1afce266ee8168041cf81f
https://hdl.handle.net/2066/218235

Clinical Goals and Barriers to Effective Psoriasis Care

Autor: Colin Theng, Marc Bourcier, Craig L. Leonardi, Bruce Strober, Lars Iversen, Jashin J. Wu, Ronald Vender, Johann E. Gudjonsson, April W. Armstrong, Alexa B. Kimball, Charles N. Ellis, Arnon D. Cohen, Andrew Yule Finlay, Alice B. Gottlieb, Charles Lynde, Claudia de la Cruz, Andre V. E. de Carvalho, Caitriona Ryan, Edgardo Chouela, C. Elise Kleyn, Joelle M. van der Walt, Fernando Valenzuela, Helen S. Young

Publikováno v: Dermatology and Therapy, Vol 9, Iss 1, Pp 5-18 (2018)
Dermatology and Therapy
Strober, B E, van der Walt, J M, Armstrong, A W, Bourcier, M, Carvalho, A V E, Chouela, E, Cohen, A D, de la Cruz, C, Ellis, C N, Finlay, A Y, Gottlieb, A B, Gudjonsson, J E, Iversen, L, Kleyn, C E, Leonardi, C L, Lynde, C W, Ryan, C, Theng, C T, Valenzuela, F, Vender, R, Wu, J J, Young, H S & Kimball, A B 2019, ' Clinical Goals and Barriers to Effective Psoriasis Care ', Dermatology and therapy, vol. 9, no. 1, pp. 5-18 . https://doi.org/10.1007/s13555-018-0279-5
Strober, B E, van der Walt, J M, Armstrong, A W, Bourcier, M, Carvalho, A V E, Chouela, E, Cohen, A D, de la Cruz, C, Ellis, C N, Finlay, A Y, Gottlieb, A B, Gudjonsson, J E, Iversen, L, Kleyn, C E, Leonardi, C L, Lynde, C W, Ryan, C, Theng, C T, Valenzuela, F, Vender, R, Wu, J J, Young, H S & Kimball, A B 2019, ' Clinical Goals and Barriers to Effective Psoriasis Care ', Dermatology and Therapy, vol. 9, no. 1, pp. 5-18 . https://doi.org/10.1007/s13555-018-0279-5

Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long roundtable discussion with the primary purpose to discuss the treatment goals of psoriasis patients and worldwide barriers to optimal care. Setting clear e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74510bcf008580162fe7247b58f97f5
http://link.springer.com/article/10.1007/s13555-018-0279-5

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings:A Study from the International Psoriasis Council

Autor: Bradley S. Stolshek, Mona L. Martin, Joelle M. van der Walt, Richard B. Warren, Bruce Strober, Andre V. E. de Carvalho, Peter C.M. van de Kerkhof, Claudia de la Cruz, Yves Poulin, Kristina Callis Duffin

Publikováno v: Strober, B, van de Kerkhof, P C M, Callis Duffin, K, Poulin, Y, Warren, R B, de la Cruz, C, van der Walt, J M, Stolshek, B S, Martin, M L & de Carvalho, A V E 2019, ' Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings : A Study from the International Psoriasis Council ', American journal of clinical dermatology . https://doi.org/10.1007/s40257-019-00458-2
American Journal of Clinical Dermatology
American Journal of Clinical Dermatology, 20, 699-709
American Journal of Clinical Dermatology, 20, 5, pp. 699-709

Background The Psoriasis Symptom Inventory (PSI) is a patient-reported outcome measure designed to assess psoriasis signs and symptoms. Objectives The aim was to assess the usefulness of the PSI in enhancing patient care in the clinical setting. Meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f183beea868593a5f3904e264580b66a
https://research.manchester.ac.uk/en/publications/3659770c-9784-4088-8d14-ab0fa88ef014

Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America

Autor: Joelle M. van der Walt, Angela M. Londoño Garcia, Fernando Valenzuela, Cesar González, Claudia de la Cruz, Ricardo Romiti, J. S. Redfern, Nancy Podoswa, Gladys L. Dorantes, A. V. Carvalho, Matías Maskin

Publikováno v: The Journal of Dermatology. 44:3-12

Latin American countries view biosimilar agents as an effective approach to curtail health-care expenditures while maintaining the safety and efficacy profile of their branded innovator comparators. To understand the complexities of the regulatory la

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376ce7ad63c52122d19530c44069ec24
https://doi.org/10.1111/1346-8138.13512